Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: results from the MAVERIC phase II trial
Year: 2025
Type: article
Language: en
Topic: Neuroendocrine Tumor Research Advances
Authors and affiliations:
raw_author_name: Lorenzo Antonuzzo
raw_affiliation_strings: Department of Experimental Clinical Medicine, University of Florence , Florence 50134,
Oncology Unit, Careggi University Hospital , Florence 50134,
raw_author_name: Daniele Lavacchi
raw_affiliation_strings: Oncology Unit, Careggi University Hospital , Florence 50134,
raw_author_name: Francesca Spada
raw_affiliation_strings: Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS , Milan 20141,
raw_author_name: Riccardo Marconcini
raw_affiliation_strings: Medical Oncology, Dipartimento di Oncologia Medica, AOU Pisana—Stabilimento di Santa Chiara , Pisa 56126,
raw_author_name: Fabio Gelsomino
raw_affiliation_strings: Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena , Modena 41125,
raw_author_name: Vito Amoroso
raw_affiliation_strings: Medical Oncology Unit, Azienda Socio-Sanitaria Territoriale (ASST) Spedali Civili di Brescia , Genova 16132,
raw_author_name: Federica Cosso
raw_affiliation_strings: Department of Experimental Clinical Medicine, University of Florence , Florence 50134,
raw_author_name: Elisa Pellegrini
raw_affiliation_strings: Oncology Unit, Careggi University Hospital , Florence 50134,
raw_author_name: Federico Scolari
raw_affiliation_strings: Department of Experimental and Clinical Biomedical Sciences, University of Florence , Genova 16132,
raw_author_name: Clotilde Sparano
raw_affiliation_strings: Department of Experimental and Clinical Biomedical Sciences, University of Florence , Genova 16132,
raw_author_name: Giulia Massaro
raw_affiliation_strings: Department of Experimental Clinical Medicine, University of Florence , Florence 50134,
raw_author_name: Elisa Giommoni
raw_affiliation_strings: Oncology Unit, Careggi University Hospital , Florence 50134,
raw_author_name: Luca Messerini
raw_affiliation_strings: Department of Experimental Clinical Medicine, University of Florence , Florence 50134,
raw_author_name: Daniele Rossini
raw_affiliation_strings: Department of Experimental Clinical Medicine, University of Florence , Florence 50134,
Oncology Unit, Careggi University Hospital , Florence 50134,
raw_author_name: Marco Brugia
raw_affiliation_strings: Oncology Unit, Careggi University Hospital , Florence 50134,
raw_author_name: Francesco Di Costanzo
raw_affiliation_strings: Oncology Unit, Careggi University Hospital , Florence 50134,
raw_author_name: Luca Boni
raw_affiliation_strings: Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino , Genova 16132,
raw_author_name: Massimo Milione
raw_affiliation_strings: First Pathology Unit, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan 20133,
raw_author_name: Serena Pillozzi
raw_affiliation_strings: Department of Experimental and Clinical Biomedical Sciences, University of Florence , Genova 16132,
raw_author_name: Nicola Fazio
raw_affiliation_strings: Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS , Milan 20141,